ScreenPoint Medical Deploys Transpara Breast AI at Johns Hopkins Medicine to Enhance Cancer Detection

ScreenPoint Medical’s Transpara Breast AI has been deployed at Johns Hopkins Medicine to improve cancer detection for breast cancer screening patients, benefiting radiologists and patients across 50 sites in 5 states and the District of Columbia. The decision to implement Transpara followed a thorough evaluation of the software’s evidence, effectiveness, and performance by the breast imaging team at Johns Hopkins. The aim is to enhance screening workflow, decision confidence, and breast cancer diagnostic assessment, ultimately aiding radiologists in the early detection of breast cancer and reducing recall rates.